|
|
|
 |
 |
|
||||||||||||||||||||||||||||||||
|
|
|||||||
|
Budesonide is a potent, locally acting corticosteroid (strong glucocorticoid, weak mineralocorticoid). In humans, the enteric-coated oral form is used for the treatment or management of Crohn's disease and the inhaled formulations are used for management of asthma and allergies. Because of its low systemic bioavailability and high first-pass hepatic metabolism, it is regarded as a "topical" corticosteroid at the site of delivery. In large-scale clinical trials in humans with mild to moderate Crohn's disease, budesonide was well tolerated with fewer corticosteroid-related adverse effects than prednisolone. The presence of food in the GI tract will affect the speed but not the amount of the drug that is absorbed.
IBD is a common problem and a diagnostic challenge in small animal practice. It is seen in both dogs and cats, although the presentation is somewhat different. The diagnosis of IBD is based on histologic evidence of inflammation in the intestine. Further classification is based on the affected region of the intestine and the predominant cell type in the infiltrate. Diagnostic tests include CBC, chemistry, fecal cytology and parasitology, urinalysis, abdominal radiograph and ultrasound, and, ultimately, intestinal biopsy. There are some breeds including Basenji's, Wheaten Terriors, Boxers and Norwegian Lundehunds with an increased incidence of specific forms of IBD. Animals are rarely cured of IBD unless a specific underlying cause (such as parasitism) is determined and, more commonly, the goal of therapy is control of clinical signs with the minimum amount of drugs. The majority of cats with IBD (85 percent) respond favorably to corticosteroid therapy.
Budesonide is a newer corticosteroid that, in some instances, can replace prednisone or prednisolone for immunosuppression therapy. Although research has demonstrated hypothalamopituitary-adrenal suppression in normal dogs receiving budesonide, many side effects associated with long term corticosteroid therapy were not as apparent.
The human budesonide product is enteric coated; non-enteric coated formulations may be preferable in small animals because the location of IBD tends to be more proximal within the GI tract in dogs and cats.
• Although corticosteroid-related side effects are less common with budesonide, they include polyuria, polydypsia, increased appetite and changes in hair coat.
• Budesonide should be used with caution in animals with decreased liver function.
• Because budesonide is a corticosteroid, it should be used with additional caution in animals with GI ulceration, active infection, diabetes or cataracts. Additional corticosteroid supplementation may be needed for budesonide-treated animals undergoing surgery.
• There has been positive research in humans on the use of budesonide during pregnancy for women with Crohn's disease. The FDA considers budesonide a Category C drug.
• Budesonide should not be used concomitantly with erythromycin, cimetidine, ketoconazole, itraconazole, fluconazole and diltiazem. Budesonide is metabolized by a hepatic enzyme (CYP3A), which is inhibited by these drugs.
• Oral antacids will dissolve the enteric coating of budesonide. Simultaneous dosing with omeprazole has been studied in humans and does not affect the pharmacokinetics of budesonide.
• Experimentally, massive (100x) overdose was lethal in mice. In the event of overdose, prompt gut evacuation may be indicated.
Dr.
Barbara Forney is a veterinary practitioner in Chester County, Pennsylvania.
She has a master's degree in animal science from the University of Delaware
and graduated from the University of Pennsylvania School of Veterinary Medicine
in 1982.
She began to develop her interest in client education and medical writing 1997. Recent publications include portions of The Pill Book Guide to Medication for Your Dog and Cat, and most recently Understanding Equine Medications published by the Bloodhorse.
Dr. Forney is an FEI veterinarian and an active member of the AAEP, AVMA, and AMWA.
You can purchase books by Dr. Forney at www.exclusivelyequine.com
The information contained on this site
is general in nature and is intended for use as an informational aid. It does
not cover all possible uses, actions, precautions, side effects, or interactions
of the products shown, nor is the information intended as medical advice or
diagnosis for individual health problems or for making an evaluation as to the
risks and benefits of using a particular product. You should consult your doctor
about diagnosis and treatment of any health problems. Information and statements
have not been evaluated by the Food and Drug Administration ("FDA"),
nor has the FDA approved the products to diagnose, cure or prevent disease.
Wedgewood compounded veterinary medicines are not intended for use in food and food-producing animals.
Request a Brochure | Request a Formulation Consultation
Compound Medications | Veterinary
Medicine | Compounding Pharmacy | Veterinary
Medications
Information on Expired Medications | Sitemap
Wedgewood Pharmacy
405 Heron Drive Suite 200 • Swedesboro, NJ 08085-1749 • 1-888-678-1967
Copyright © 2004-2008 Wedgewood Village Pharmacy, Inc. All rights reserved.
